EGFR G796D mutation mediates resistance to osimertinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EGFR G796D mutation mediates resistance to osimertinib

Published:2017-05-16 Issue:30 Volume:8 Page:49671-49679
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zheng Di¹,Hu Min²,Bai Yu²,Zhu Xuehua²,Lu Xuesong³,Wu Chunyan⁴,Wang Jiying¹,Liu Li¹,Wang Zheng³,Ni Jian¹,Yang Zhenfan²,Xu Jianfang¹

Affiliation:

1. Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School, Shanghai, China

2. IMED Asia, AstraZeneca, Shanghai, China

3. Research and Development Information, AstraZeneca, Shanghai, China

4. Department of Pathology, Shanghai Pulmonary Hospital, Tongji University Medical School, Shanghai, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors;Future Medicinal Chemistry;2024-08-29

2. Targeting Solvent-Front Mutations for Kinase Drug Discovery: From Structural Basis to Design Strategies;Journal of Medicinal Chemistry;2024-08-15

3. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

4. Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges;Frontiers in Immunology;2024-04-09

5. Non-small cell lung cancer: an update on emerging EGFR-targeted therapies;Expert Opinion on Emerging Drugs;2024-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP